StonvexLoading…
StonvexStonvexStonvexCore line items from AOMR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $40.69M | $143.66M | $104.62M | $67.96M |
Operating Income | $-7.38M | $44.55M | $33.02M | $21.30M |
Net Income | $-7.38M | $44.02M | $32.71M | $21.30M |
EPS (Diluted) | $-0.30 | $1.80 | $1.36 | $0.89 |
Total Assets | $2.81B | $2.75B | $2.64B | $2.55B |
Total Liabilities | $2.55B | $2.48B | $2.37B | $2.31B |
Cash & Equivalents | $41.96M | $41.62M | $51.60M | $40.50M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 24.91M | 24.91M | 24.91M | 23.77M |